Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis (Q40485583)

20 September 2017

title

Targeting VEGF-A with a vaccine decreases inflammation and joint destruction in experimental arthritis (English)

1 reference

20 September 2017

0 references

10

1 reference

20 September 2017

Luca Semerano

1

1 reference

20 September 2017

Emilie Duvallet

2

1 reference

20 September 2017

Nadia Belmellat

3

1 reference

20 September 2017

Nicolas Marival

4

1 reference

20 September 2017

Nicolas Schall

5

1 reference

20 September 2017

Maëlle Monteil

6

1 reference

20 September 2017

Géraldine Grouard-Vogel

7

1 reference

20 September 2017

Emilie Bernier

8

1 reference

20 September 2017

Marc Lecouvey

9

1 reference

20 September 2017

Sylviane Muller

11

1 reference

20 September 2017

Marie-Christophe Boissier

12

1 reference

20 September 2017

Eric Assier

13

1 reference

20 September 2017

publication date

29 September 2015

1 reference

20 September 2017

1 reference

20 September 2017

volume

19

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

39-52

1 reference

Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Blood vessels, a potential therapeutic target in rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Vascular endothelial growth factor family of ligands and receptors: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Protection from articular damage by passive or active anti-tumour necrosis factor (TNF)-α immunotherapy in human TNF-α transgenic mice depends on anti-TNF-α antibody levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

The impact of Bevacizumab (Avastin) on survival in metastatic solid tumors--a meta-analysis and systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: multiple copy flexibility and receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Structural Basis for Selective Vascular Endothelial Growth Factor-A (VEGF-A) Binding to Neuropilin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

TGF-beta1 induces mouse dendritic cells to express VEGF and its receptor (Flt-1) under hypoxic conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

VEGFA/VEGFR2-targeted therapies prevent the VEGFA-induced proliferation of regulatory T cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Interplay between TNF and regulatory T cells in a TNF-driven murine model of arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

TNFα: activator or inhibitor of regulatory T cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Toward a new generation of vaccines: the anti-cytokine therapeutic vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Active immunization against murine TNFalpha peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Double-antiangiogenic protein DAAP targeting vascular endothelial growth factor A and angiopoietins attenuates collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Avastin exhibits therapeutic effects on collagen-induced arthritis in rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Intravenous administration of anti-vascular endothelial growth factor humanized monoclonal antibody bevacizumab improves articular cartilage repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Interaction between bevacizumab and murine VEGF-A: a reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Therapeutic effect of anti-vascular endothelial growth factor receptor I antibody in the established collagen-induced arthritis mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-alpha and IL-6 by human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Active immunization to tumor necrosis factor-alpha is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

Therapeutic vaccination with TNF-Kinoid in TNF antagonist-resistant rheumatoid arthritis: a phase II randomized, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-015-9487-0

10.1007/S10456-015-9487-0

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1026116557

0 references

1 reference